Finance

Lists
Why is DERM up 2.12%?
Dive Deeper
DERM:NASDAQ
Journey Medical Corp
$6.27
+2.12%
(+0.13) 1D
Sep 28, 9:56:53 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DERM...
Open
$6.11
High
$6.32
Low
$6.08
Mkt. cap
139.35M
Avg. vol.
184.03K
Volume
20.70K
52-wk high
$9.55
52-wk low
$4.31
EPS
-$0.23
Beta
1.09
Shares outstanding
22.22M
No. of employees
58
Open
$6.11
High
$6.32
Low
$6.08
Mkt. cap
139.35M
Avg. vol.
184.03K
Volume
20.70K
52-wk high
$9.55
52-wk low
$4.31
EPS
-$0.23
Beta
1.09
Shares outstanding
22.22M
No. of employees
58
News stories
From web sources and news partners
About Journey Medical Corp
CEO-
Employees58
Founded2014
HeadquartersScottsdale, Arizona, United States
SectorPharmaceutical industry
Websitejourneymedicalcorp.com
Analyst ratings
Based on 2 analysts giving stock ratings to DERM in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DERM in the last 3 months.
Highest
Current $6.27
$14.00 (+123.29%)
Average
$13.50 (+115.31%)
Lowest
$13.00 (+107.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
$13.00
+107.3%
09/21/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$14.00
+123.3%
08/13/2026
Thomas Flaten
Lake Street
Buy
Maintained
$13.00
+107.3%
05/14/2026
Unknown Analyst
Alliance Global Partners
Buy
Reiterated
$16.00
+155.2%
03/26/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
$12.00
+91.4%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
17.63M
16.08M
15.96M
18.51M
Cost of goods sold
5.76M
5.44M
6.22M
6.14M
Cost of revenue
5.76M
5.44M
6.22M
6.14M
Research and development expenses
287.00K
154.00K
-
54.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.05M
9.86M
10.11M
10.89M
Operating expense
13.40M
11.08M
11.24M
11.91M
Total operating expenses
19.16M
16.52M
17.45M
18.05M
Operating income
-1.53M
-443.00K
-1.49M
456.00K
Other non operating income
-
-
-
-
EBT including unusual items
-2.32M
-1.25M
-2.23M
-297.00K
EBT excluding unusual items
-2.32M
-1.25M
-2.23M
-297.00K
Income tax expense
-
-
-
15.00K
Effective tax rate
-
-
-
-5.05%
Other operating expenses
-
-
-
-
Net income
-2.32M
-1.25M
-2.23M
-312.00K
Net profit margin
-13.13%
-7.76%
-13.97%
-1.69%
Earnings per share
-
-
-
-
Interest and investment income
154.00K
148.00K
157.00K
154.00K
Interest expense
-937.00K
-933.00K
-892.00K
-906.00K
Net interest expenses
-783.00K
-785.00K
-735.00K
-752.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-465.00K
622.00K
-366.00K
1.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps